desoxycorticosterone acetate has been researched along with Heart Failure in 12 studies
Desoxycorticosterone Acetate: The 21-acetate derivative of desoxycorticosterone.
Heart Failure: A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Calcitriol treatment attenuated FGF23-induced cardiac fibrosis and improved diastolic function via inhibition of transforming growth factor-β signaling." | 1.91 | Fibroblast Growth Factor 23 Exacerbates Cardiac Fibrosis in Deoxycorticosterone Acetate-Salt Mice With Hypertension. ( Honda, H; Kato, T; Koiwa, F; Mizobuchi, M; Ogata, H; Saito, T, 2023) |
| "Metformin-treated mice have unaltered PEVK phosphorylation but increased phosphorylation of PKA sites in the N2B element, a change which has previously been shown to lower titin's stiffness." | 1.51 | Metformin improves diastolic function in an HFpEF-like mouse model by increasing titin compliance. ( Gotthardt, M; Granzier, HL; Liss, M; Methawasin, M; Slater, RE; Strom, JG; Sweitzer, N, 2019) |
| "Obesity and hypertension are prevalent comorbidities in heart failure with preserved ejection fraction." | 1.51 | Limited synergy of obesity and hypertension, prevalent risk factors in onset and progression of heart failure with preserved ejection fraction. ( Brandt, MM; Cheng, C; Cramer, MJ; Duncker, DJ; Joles, JA; Krebber, MM; Mokry, M; Nguyen, ITN; van de Wouw, J; Verhaar, MC, 2019) |
| "We induced hypertension and hyperlipidemia in landrace pigs (n = 8) by deoxycorticosteroneacetate (DOCA, 100 mg/kg, 90-day-release subcutaneous depot) and a Western diet (WD) containing high amounts of salt, fat, cholesterol, and sugar for 12 wk." | 1.42 | A porcine model of hypertensive cardiomyopathy: implications for heart failure with preserved ejection fraction. ( Alogna, A; Casadei, B; Eller, K; Eller, P; Hamdani, N; Höfler, G; Kirsch, A; Linke, WA; Maechler, H; Manninger, M; Pieske, BM; Post, H; Reilly, S; Schauer, S; Schwarzl, M; Seiler, S; Steendijk, P; Verderber, J; Zirngast, B; Zweiker, D, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (25.00) | 24.3611 |
| 2020's | 6 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hao, J | 1 |
| Chang, L | 1 |
| Wang, D | 1 |
| Ji, C | 1 |
| Zhang, S | 1 |
| Hou, Y | 1 |
| Wu, Y | 1 |
| Wu, H | 2 |
| Tang, LX | 2 |
| Wang, XM | 2 |
| Li, LP | 2 |
| Chen, XK | 2 |
| He, YJ | 2 |
| Yang, DZ | 2 |
| Shi, Y | 2 |
| Shou, JL | 2 |
| Zhang, ZS | 2 |
| Wang, L | 2 |
| Lu, BJ | 2 |
| An, SM | 2 |
| Zeng, CY | 2 |
| Wang, WE | 2 |
| Saito, T | 1 |
| Mizobuchi, M | 1 |
| Kato, T | 1 |
| Ogata, H | 1 |
| Koiwa, F | 1 |
| Honda, H | 1 |
| Samuelsson, AM | 1 |
| Bartolomaeus, TUP | 1 |
| Anandakumar, H | 1 |
| Thowsen, I | 1 |
| Nikpey, E | 1 |
| Han, J | 1 |
| Marko, L | 1 |
| Finne, K | 1 |
| Tenstad, O | 1 |
| Eckstein, J | 1 |
| Berndt, N | 1 |
| Kühne, T | 1 |
| Kedziora, S | 1 |
| Sultan, I | 1 |
| Skogstrand, T | 1 |
| Karlsen, TV | 1 |
| Nurmi, H | 1 |
| Forslund, SK | 1 |
| Bollano, E | 1 |
| Alitalo, K | 1 |
| Muller, DN | 1 |
| Wiig, H | 1 |
| Smart, CD | 1 |
| Fehrenbach, DJ | 1 |
| Wassenaar, JW | 1 |
| Agrawal, V | 1 |
| Fortune, NL | 1 |
| Dixon, DD | 1 |
| Cottam, MA | 1 |
| Hasty, AH | 1 |
| Hemnes, AR | 1 |
| Doran, AC | 1 |
| Gupta, DK | 1 |
| Madhur, MS | 1 |
| Hao, JM | 1 |
| Sun, P | 1 |
| Zeng, Y | 1 |
| Zhang, H | 1 |
| Zhang, ZD | 1 |
| Chang, LP | 1 |
| Hou, YL | 1 |
| Slater, RE | 1 |
| Strom, JG | 1 |
| Methawasin, M | 1 |
| Liss, M | 1 |
| Gotthardt, M | 1 |
| Sweitzer, N | 1 |
| Granzier, HL | 1 |
| Brandt, MM | 1 |
| Nguyen, ITN | 1 |
| Krebber, MM | 1 |
| van de Wouw, J | 1 |
| Mokry, M | 1 |
| Cramer, MJ | 1 |
| Duncker, DJ | 1 |
| Verhaar, MC | 1 |
| Joles, JA | 1 |
| Cheng, C | 1 |
| Schwarzl, M | 1 |
| Hamdani, N | 1 |
| Seiler, S | 1 |
| Alogna, A | 1 |
| Manninger, M | 1 |
| Reilly, S | 1 |
| Zirngast, B | 1 |
| Kirsch, A | 1 |
| Steendijk, P | 1 |
| Verderber, J | 1 |
| Zweiker, D | 1 |
| Eller, P | 1 |
| Höfler, G | 1 |
| Schauer, S | 1 |
| Eller, K | 1 |
| Maechler, H | 1 |
| Pieske, BM | 1 |
| Linke, WA | 1 |
| Casadei, B | 1 |
| Post, H | 1 |
| DAVIS, JO | 1 |
| HOWELL, DS | 1 |
| SOUTHWORTH, JL | 1 |
| SCHWEITZER, P | 1 |
| NEUBAUER, E | 1 |
| STANCAK, A | 1 |
| PRINO, G | 1 |
12 other studies available for desoxycorticosterone acetate and Heart Failure
| Article | Year |
|---|---|
Periplocin Alleviates Cardiac Remodeling in DOCA-Salt-Induced Heart Failure Rats.
Topics: Animals; Desoxycorticosterone Acetate; Heart Failure; Myocytes, Cardiac; Rats; Stroke Volume; Ventri | 2023 |
Porcupine inhibitor CGX1321 alleviates heart failure with preserved ejection fraction in mice by blocking WNT signaling.
Topics: Animals; Cardiomegaly; Cardiomyopathies; Desoxycorticosterone Acetate; Fibrosis; Heart Failure; Mice | 2023 |
Porcupine inhibitor CGX1321 alleviates heart failure with preserved ejection fraction in mice by blocking WNT signaling.
Topics: Animals; Cardiomegaly; Cardiomyopathies; Desoxycorticosterone Acetate; Fibrosis; Heart Failure; Mice | 2023 |
Porcupine inhibitor CGX1321 alleviates heart failure with preserved ejection fraction in mice by blocking WNT signaling.
Topics: Animals; Cardiomegaly; Cardiomyopathies; Desoxycorticosterone Acetate; Fibrosis; Heart Failure; Mice | 2023 |
Porcupine inhibitor CGX1321 alleviates heart failure with preserved ejection fraction in mice by blocking WNT signaling.
Topics: Animals; Cardiomegaly; Cardiomyopathies; Desoxycorticosterone Acetate; Fibrosis; Heart Failure; Mice | 2023 |
Fibroblast Growth Factor 23 Exacerbates Cardiac Fibrosis in Deoxycorticosterone Acetate-Salt Mice With Hypertension.
Topics: Animals; Blood Pressure; Calcitriol; Desoxycorticosterone Acetate; Fibroblast Growth Factor-23; Fibr | 2023 |
VEGF-B hypertrophy predisposes to transition from diastolic to systolic heart failure in hypertensive rats.
Topics: Animals; Cardiomegaly; Desoxycorticosterone Acetate; Heart Failure; Heart Failure, Systolic; Hyperte | 2023 |
Immune profiling of murine cardiac leukocytes identifies triggering receptor expressed on myeloid cells 2 as a novel mediator of hypertensive heart failure.
Topics: Animals; Cardiomyopathies; Desoxycorticosterone Acetate; Heart Failure; Humans; Hypertension; Leukoc | 2023 |
Qiliqiangxin capsule improves cardiac remodeling in rats with DOCA-salt-induced diastolic dysfunction.
Topics: Animals; Cytokines; Desoxycorticosterone Acetate; Heart Failure; Interleukin-10; Matrix Metalloprote | 2023 |
Metformin improves diastolic function in an HFpEF-like mouse model by increasing titin compliance.
Topics: Animals; Desoxycorticosterone Acetate; Diastole; Disease Models, Animal; Heart Failure; Heart Ventri | 2019 |
Limited synergy of obesity and hypertension, prevalent risk factors in onset and progression of heart failure with preserved ejection fraction.
Topics: Animals; Apoptosis; Capillaries; Desoxycorticosterone Acetate; Disease Progression; Fatty Acids; Fib | 2019 |
A porcine model of hypertensive cardiomyopathy: implications for heart failure with preserved ejection fraction.
Topics: Animals; Cardiomyopathies; Connectin; Desoxycorticosterone Acetate; Diet, Western; Dilatation, Patho | 2015 |
Mechanisms of fluid and electrolyte retention in experimental preparations in dogs. III. Effect of adrenalectomy and subsequent desoxycorticosterone acetate administration on ascites formation.
Topics: Adrenal Cortex; Adrenalectomy; Animals; Ascites; Desoxycorticosterone; Desoxycorticosterone Acetate; | 1953 |
[THE EFFECT OF DOCA ON MUSCLE METABOLISM IN CARDIAC DECOMPENSATION].
Topics: Carbon Dioxide; Desoxycorticosterone; Desoxycorticosterone Acetate; Glucose; Heart Failure; Metaboli | 1963 |
[Reaction of chlorothiazide in fluid retention induced by pitressin and desoxycorticosterone acetate in rats].
Topics: Animals; Chlorothiazide; Desoxycorticosterone; Desoxycorticosterone Acetate; Heart Failure; Rats; Va | 1959 |